Notice: This company has been marked as potentially delisted and may not be actively trading. Alexion Pharmaceuticals (ALXN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Alexion, DHL partner for sustainable air delivery of medicine in IrelandFebruary 14, 2025 | msn.comMonopar's Incredible Journey From $5 To $50 In Less Than 5 MonthsFebruary 6, 2025 | markets.businessinsider.comMonopar Therapeutics Stock Hits 52-Week High at $38.91January 23, 2025 | msn.comAstraZeneca's Alexion Inks Deal With Pan-Canadian Pharmaceutical AllianceDecember 18, 2024 | markets.businessinsider.comMonopar Therapeutics Secures License for Wilson Disease TreatmentOctober 25, 2024 | finance.yahoo.comAlexion’s Voydeya gains FDA approval for extravascular haemolysisApril 2, 2024 | msn.comUS FDA grants approval for Alexion’s NMOSD treatmentMarch 27, 2024 | msn.comJCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with AlexionMarch 19, 2024 | businesswire.comCitius Pharmaceuticals (CTXR) Earnings Watch: Pharma Stock Signals for InvestorsDecember 11, 2023 | stocknews.comLevi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. (ALXN) an Upcoming Claims Deadline in a Class Action SettlementDecember 8, 2023 | markets.businessinsider.comBioMarin Pharma gains on report Elliott has a stakeNovember 7, 2023 | investing.comGilead Sciences (GILD) Earnings Forecast and GameplanNovember 6, 2023 | stocknews.comAlexion and Verge enter AI-powered drug discovery dealSeptember 11, 2023 | msn.comAlexion Pharmaceuticals Inc (A1LX34)May 13, 2023 | investing.comWilson Disease Drugs Market Size, Growth Strategies, Gross Margin and Forecast 2029April 25, 2023 | marketwatch.comAlexion Reaches New 52-Week High (ALXN)April 10, 2023 | thestreet.comAlexion advances commitment to transform patient outcomes in rare neurological diseases at AAN 2023March 4, 2023 | stockhouse.comAstraZeneca goes for growth with new drugs as COVID sales waneFebruary 9, 2023 | investing.comHealthcare Sector Is Lagging As We Enter 2022 Earnings SeasonJanuary 25, 2023 | seekingalpha.comSynageva Biopharma (GEVA) Stock More Than Doubles to 52-Week High on Alexion AcquisitionJanuary 21, 2023 | thestreet.comAlexion aims to advance NMOSD treatment landscape with exceptional ULTOMIRIS® (ravulizumab-cwvz) efficacy data at ECTRIMS 2022October 14, 2022 | finance.yahoo.comUS close: Dow loses almost 1,300 points after hot CPI readingSeptember 15, 2022 | lse.co.ukAlexion Stock Hits New 52-Week High (ALXN)September 1, 2022 | thestreet.comFTSE 100 positive but off best levels, US seen higherJuly 29, 2022 | uk.investing.comAstraZeneca's Unit Alexion To Pay $775 Mln To Chugai On Ultomiris Patent SettlementMarch 17, 2022 | markets.businessinsider.comAstraZeneca inks $760 million deal with Swiss firm Neurimmune for antibody drugMarch 1, 2022 | uk.investing.comUK pre-market stocks update – Shell, AstraZeneca, Aston Martin, C&CJanuary 7, 2022 | msn.comWas The Smart Money Right About Piling Into Microchip Technology Incorporated (MCHP)?November 8, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)October 26, 2021 | finance.yahoo.comAstraZeneca Buys Fortress-Biotech Founded Caelum For $500MSeptember 29, 2021 | feeds.benzinga.comAstraZeneca buys rare disease drugmaker Caelum in potential $500 mln dealSeptember 29, 2021 | financialpost.comAlexion Must Face Claims Of Stalling On Drug After MergerSeptember 3, 2021 | law360.comWere Hedge Funds Right About Alexion Pharmaceuticals, Inc. (ALXN)?August 9, 2021 | finance.yahoo.comAlexion Pharmaceuticals Inc ALXN-MXJuly 24, 2021 | cnbc.comAstraZeneca Wraps Its Massive Alexion Buyout — Is AZN Stock A Buy Or Sell?July 23, 2021 | finance.yahoo.comAlexion Pharmaceuticals (ALXN) Earnings Expected to Grow: Should You Buy?July 22, 2021 | finance.yahoo.com Get Alexion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXN and its competitors with MarketBeat's FREE daily newsletter. Email Address ALXN Media Mentions By Week ALXN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALXN News Sentiment▼0.490.60▲Average Medical News Sentiment ALXN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALXN Articles This Week▼00▲ALXN Articles Average Week Get Alexion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMGN News GILD News VRTX News REGN News ALNY News BIIB News UTHR News INCY News BMRN News NBIX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALXN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alexion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alexion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
